Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Biotech

Lilly raises diabetes weight-loss bar with amylin-Zepbound combo

The highest dose of Lilly's amylin-Zepbound combo yielded average weight loss of 54.1-pounds at 48 weeks, with A1C-lowering benefits shown, too.

Marissa Russo Sep 30, 2026 1:52pm

Judge gavel with bright glowing futuristic orange neon lights

Beam sues rival startup, claims former scientist stole secrets

Sep 30, 2026 10:42am

Biotech value creation at an inflection point

Brought to you by Lumanity

Merck’s anti-TL1A secures a ph. 2 hidradenitis suppurativa win

Sep 30, 2026 10:20am

How AI is reshaping biopharma decision-making

Brought to you by Clarivate

Fierce Biotech Fundraising Tracker '26: AnaCardio, Breye & more

Sep 30, 2026 9:30am